Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantitative proteomics investigation of pancreatic intraepithelial neoplasia.
Pan S, Chen R, Reimel BA, Crispin DA, Mirzaei H, Cooke K, Coleman JF, Lane Z, Bronner MP, Goodlett DR, McIntosh MW, Traverso W, Aebersold R, Brentnall TA. Pan S, et al. Among authors: coleman jf. Electrophoresis. 2009 Apr;30(7):1132-44. doi: 10.1002/elps.200800752. Electrophoresis. 2009. PMID: 19373808 Free PMC article.
Clinicopathologic Features of Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0) Breast Cancers.
Wilcock D, Sirohi D, Albertson D, Cleary AS, Coleman JF, Jedrzkiewicz J, Mahlow J, Ruano AL, Gulbahce HE. Wilcock D, et al. Among authors: coleman jf. Arch Pathol Lab Med. 2023 Nov 7. doi: 10.5858/arpa.2023-0275-OA. Online ahead of print. Arch Pathol Lab Med. 2023. PMID: 37934954 Free article.
Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer.
Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Burlingame J, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim JT, Coleman JF, Deftereos G, Gulbahce EH, Sirohi D. Wilcock DM, et al. Among authors: coleman jf. Arch Pathol Lab Med. 2023 Dec 1;147(12):1402-1412. doi: 10.5858/arpa.2022-0372-OA. Arch Pathol Lab Med. 2023. PMID: 36920020 Free article.
Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American Pathologists.
Duncavage EJ, Coleman JF, de Baca ME, Kadri S, Leon A, Routbort M, Roy S, Suarez CJ, Vanderbilt C, Zook JM. Duncavage EJ, et al. Among authors: coleman jf. J Mol Diagn. 2023 Jan;25(1):3-16. doi: 10.1016/j.jmoldx.2022.09.007. Epub 2022 Oct 13. J Mol Diagn. 2023. PMID: 36244574 Free article. Review.
Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.
Sirohi D, Schmidt RL, Aisner DL, Behdad A, Betz BL, Brown N, Coleman JF, Corless CL, Deftereos G, Ewalt MD, Fernandes H, Hsiao SJ, Mansukhani MM, Murray SS, Niu N, Ritterhouse LL, Suarez CJ, Tafe LJ, Thorson JA, Segal JP, Furtado LV. Sirohi D, et al. Among authors: coleman jf. J Mol Diagn. 2020 Feb;22(2):284-293. doi: 10.1016/j.jmoldx.2019.10.010. Epub 2019 Dec 16. J Mol Diagn. 2020. PMID: 31837433 Free article.
27 results